|
SIL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64879221387082E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.42870000052753E-07 |
| Normal-vs-Stage2 |
4.791700E-04 |
| Normal-vs-Stage3 |
4.69880000464329E-08 |
| Normal-vs-Stage4 |
8.39699999977128E-07 |
| Stage1-vs-Stage2 |
4.062400E-01 |
| Stage1-vs-Stage3 |
1.620570E-01 |
| Stage1-vs-Stage4 |
2.632100E-02 |
| Stage2-vs-Stage3 |
8.488600E-01 |
| Stage2-vs-Stage4 |
3.700000E-01 |
| Stage3-vs-Stage4 |
3.491800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.88324919495153E-12 |
| Normal-vs-AfricanAmerican |
3.69310000000178E-05 |
| Normal-vs-Asian |
7.723400E-01 |
| Caucasian-vs-AfricanAmerican |
6.239800E-02 |
| Caucasian-vs-Asian |
2.920600E-01 |
| AfricanAmerican-vs-Asian |
1.341580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.65280020173009E-10 |
| Normal-vs-Female |
2.14189999070413E-10 |
| Male-vs-Female |
2.434400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.260200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.91560000984259E-09 |
| Normal-vs-Age(61-80Yrs) |
3.33420002718299E-09 |
| Normal-vs-Age(81-100Yrs) |
1.001590E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.733800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.233600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.454300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.206600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.715840E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.825700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.786400E-01 |
| Normal-vs-Grade 2 |
3.365400E-04 |
| Normal-vs-Grade 3 |
2.99760216648792E-14 |
| Normal-vs-Grade 4 |
2.80130000307466E-08 |
| Grade 1-vs-Grade 2 |
7.128600E-01 |
| Grade 1-vs-Grade 3 |
9.364000E-02 |
| Grade 1-vs-Grade 4 |
5.093600E-02 |
| Grade 2-vs-Grade 3 |
2.048900E-04 |
| Grade 2-vs-Grade 4 |
1.821980E-04 |
| Grade 3-vs-Grade 4 |
2.580600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.54989999995503E-06 |
| Normal-vs-ccB subtype |
1.67409999995982E-06 |
| ccA subtype-vs-ccB subtype |
4.821800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.35319999650108E-08 |
| Normal-vs-N1 |
2.344800E-03 |
| N0-vs-N1 |
3.332200E-01 |
|
|
